1124 GMT - L'Oreal's first-quarter sales figures seem strong and relieve the vast majority of investor concerns, UBS analysts write in a research note. The French cosmetics company booked sales of EUR11.24 billion for the first three months, up 8.3% in reported terms compared with the prior-year period. Investors were concerned by a potential slowdown in North America and in the dermocosmetics market, as well as a deterioration in North Asia, UBS says. "These worries were successfully addressed," the analysts say, noting that the company posted growth in North America and a sequential improvement in North Asia. However, the second quarter is likely to be the most challenging one of the year, partly due to a difficult comparison base, the analysts say. Shares are up 4.2% at EUR441.30. (andrea.figueras@wsj.com)
(END) Dow Jones Newswires
April 19, 2024 07:24 ET (11:24 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments